Cancer stem cells (CSCs) represent a specialized subset within tumors, endowed with the remarkable ability to self-renew and diversify, thus fueling tumor progression and recurrence. They stand out for their resilience against traditional cancer therapies, surviving treatments that typically eliminate the bulk of tumor cells. CSCs bear resemblance to normal stem cells, exhibiting specific surface markers and the capacity to initiate tumors in experimental models. The pursuit of CSC-targeted therapies holds significant promise in cancer research, aiming to dismantle the foundation of tumor growth and thwart its resurgence. Deciphering the intricacies of CSC biology stands as a pivotal endeavor, potentially paving the way for the development of more potent and enduring treatments against cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States